540222:BOM
Laurus Labs Ltd
₹2 020,00
arrow_downward
-0,79%(-16,00) 1D
15 Okt., 15:55:23 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 540222...
Open
₹2 020,00
High
₹2 046,10
Low
₹2 008,00
Mkt. cap
1,09 bn
Avg. vol.
87,29 k
Volume
20,30 k
Dividend
0,10%
Quarterly dividend
₹0,50
Ex-dividend date
08 Mei 2026
P/E ratio
99,88
52-wk high
₹2 071,00
52-wk low
₹870,05
EPS
₹20,23
Shares outstanding
106,44 m
No. of employees
7 k
Open
₹2 020,00
High
₹2 046,10
Low
₹2 008,00
Mkt. cap
1,09 bn
Avg. vol.
87,29 k
Volume
20,30 k
Dividend
0,10%
Quarterly dividend
₹0,50
Ex-dividend date
08 Mei 2026
P/E ratio
99,88
52-wk high
₹2 071,00
52-wk low
₹870,05
EPS
₹20,23
Shares outstanding
106,44 m
No. of employees
7 k
News stories
From web sources and news partners
Kalkine India
·
1 dag gelede
Laurus Labs KRKA Pharma Investment: Rs 107.8 Crore Rights Issue
TipRanks
·
2 dae gelede
Laurus Labs schedules Q2 and H1 FY27 earnings call for October 29
Profile
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
About Laurus Labs Ltd
CEOSatyanarayana Chava
Employees7,06 k
Founded2005
Headquarters-
SectorPharmaceutical industry
Websitelauruslabs.com